These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28575044)

  • 1. Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89.
    Bhatt NB; Pandya DN; Xu J; Tatum D; Magda D; Wadas TJ
    PLoS One; 2017; 12(6):e0178767. PubMed ID: 28575044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89.
    Pandya DN; Pailloux S; Tatum D; Magda D; Wadas TJ
    Chem Commun (Camb); 2015 Feb; 51(12):2301-3. PubMed ID: 25556851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for
    Seibold U; Wängler B; Wängler C
    ChemMedChem; 2017 Sep; 12(18):1555-1571. PubMed ID: 28715615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifunctional octadentate pseudopeptides as Zirconium-89 chelators for immuno-PET applications.
    Albanese V; Roccatello C; Pacifico S; Guerrini R; Preti D; Gentili S; Tegoni M; Remelli M; Bellotti D; Amico J; Gorgoni G; Cazzola E
    EJNMMI Radiopharm Chem; 2024 May; 9(1):38. PubMed ID: 38705946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes.
    Patra M; Bauman A; Mari C; Fischer CA; Blacque O; Häussinger D; Gasser G; Mindt TL
    Chem Commun (Camb); 2014 Oct; 50(78):11523-5. PubMed ID: 25132321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octadentate Zirconium(IV)-Loaded Macrocycles with Varied Stoichiometry Assembled From Hydroxamic Acid Monomers using Metal-Templated Synthesis.
    Tieu W; Lifa T; Katsifis A; Codd R
    Inorg Chem; 2017 Mar; 56(6):3719-3728. PubMed ID: 28245117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 2,3-dihydroxyterephthalamides as M(IV) chelators.
    Gramer CJ; Raymond KN
    Inorg Chem; 2004 Oct; 43(20):6397-402. PubMed ID: 15446889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Zirconium-89 Chelator Development.
    Bhatt NB; Pandya DN; Wadas TJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29534538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A streamlined synthesis for 2,3-dihydroxyterephthalamides.
    Gramer CJ; Raymond KN
    Org Lett; 2001 Sep; 3(18):2827-30. PubMed ID: 11529767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals.
    Woods JJ; Cosby AG; Wacker JN; Aguirre Quintana LM; Peterson A; Minasian SG; Abergel RJ
    Inorg Chem; 2023 Dec; 62(50):20721-20732. PubMed ID: 37590371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV).
    Guérard F; Lee YS; Brechbiel MW
    Chemistry; 2014 May; 20(19):5584-91. PubMed ID: 24740517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A macrocyclic chelator with unprecedented Th⁴⁺ affinity.
    Pham TA; Xu J; Raymond KN
    J Am Chem Soc; 2014 Jun; 136(25):9106-15. PubMed ID: 24870296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordination Chemistry of Bifunctional Chemical Agents Designed for Applications in
    Sharma AK; Schultz JW; Prior JT; Rath NP; Mirica LM
    Inorg Chem; 2017 Nov; 56(22):13801-13814. PubMed ID: 29112419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective α-metalation of THF by a cationic zirconium complex supported by an (NNNN)-type macrocyclic ligand.
    Kulinna H; Spaniol TP; Maron L; Okuda J
    Chemistry; 2013 Jul; 19(29):9468-71. PubMed ID: 23754737
    [No Abstract]   [Full Text] [Related]  

  • 17. Multifunctional Desferrichrome Analogues as Versatile
    Adams CJ; Wilson JJ; Boros E
    Mol Pharm; 2017 Aug; 14(8):2831-2842. PubMed ID: 28665620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation in amphiphilic macrocycle-substituted Gd(3+) DOTA-type chelates is affected by the regiochemistry of substitution.
    Webber BC; Cassino C; Botta M; Woods M
    Inorg Chem; 2015 Mar; 54(5):2085-7. PubMed ID: 25692481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopes.
    Wilson JJ; Ferrier M; Radchenko V; Maassen JR; Engle JW; Batista ER; Martin RL; Nortier FM; Fassbender ME; John KD; Birnbaum ER
    Nucl Med Biol; 2015 May; 42(5):428-438. PubMed ID: 25684650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals.
    Zhou X; Dong L; Shen L
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34834087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.